Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
Earnings Data
Report Date
Feb 12, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.84Last Year’s EPS
1.82Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a strong financial performance with significant growth in key segments and increased guidance for 2025. GLP-1 and Annex 1 projects are driving growth, and the Contract Manufacturing segment is performing well. However, there are challenges in the HVP Delivery Device segment, and the conclusion of the CGM contract poses a future revenue headwind. Overall, the positive aspects slightly outweigh the negatives, indicating a cautiously optimistic outlook.Company Guidance
Strong Financial Performance
Revenues of $805 million were up 5% on an organic basis, adjusted operating margins were 21.1%, and adjusted EPS of $1.96 was up 6% compared to the prior year.
Proprietary Products Segment Growth
Proprietary Products segment revenues were $648 million, up 5.1% on an organic basis, driven by HVP components with a 13% organic increase.
Increased 2025 Guidance
Guidance for 2025 was increased due to strong performance, with full-year reported revenue expected to be $3.06 billion to $3.07 billion and adjusted EPS range increased to $7.06 to $7.11.
GLP-1 and Annex 1 Growth Drivers
GLP-1 elastomers now account for 9% of total company sales, contributing significantly to the growth. Annex 1 projects are expected to deliver 200 basis points of growth this year.
Contract Manufacturing Performance
Contract Manufacturing segment delivered revenues of $157 million, growing by 4.9% organically, with strong demand for self-injected devices for obesity and diabetes.
WST Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
WST Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 23, 2025 | $277.00 | $307.25 | +10.92% |
Jul 24, 2025 | $227.12 | $278.87 | +22.79% |
Apr 24, 2025 | $217.78 | $210.21 | -3.48% |
Feb 13, 2025 | $321.70 | $198.75 | -38.22% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does West Pharmaceutical Services, Inc. (WST) report earnings?
West Pharmaceutical Services, Inc. (WST) is schdueled to report earning on Feb 12, 2026, Before Open (Confirmed).
What is West Pharmaceutical Services, Inc. (WST) earnings time?
West Pharmaceutical Services, Inc. (WST) earnings time is at Feb 12, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is WST EPS forecast?
WST EPS forecast for the fiscal quarter 2025 (Q4) is 1.84.
